Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards 2015   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Mobile   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   Videos   Comparison Tables   Spread Betting   Broker Notes   Forward Diary   Shares Magazine 


LSE Volume: 3,894 M
Avg Vol: 5,527 M -30%
Unchanged 599

FTSE rises on mixed bag as mid caps hit record

FTSE indices headed into the bank-holiday weekend on a upbeat note, the mid cap once again hitting a fresh closing high. The market took speeches by several central bank bosses in its stride, with financial, pharma and retails stocks nipping ahead, among other.

Quintain hikes FY pretax profit

Quintain Estates & Development has booked a FY pretax profit of £40.7m, from £4.7m a year ago. Revenue was £57.7m, from £32.6m. The results included a £41.2m surplus on revaluation of investment properties, from £22.4m the prior year.

SVT's profits dive

Severn Trent's FY pretax profit fell 53.5% to £148.2m, from a year earlier's profit of £318.9m. Turnover was £1.8bn, from £1.76bn. Its dividend for the 2015/16 year is set to be 80.66p.

Tungsten's hike

Tungsten Corporation has, due to strong demand from institutional investors, successfully placed a total of 21,875,985 new shares at a price of 80p each to raise £17.5m gross.

RENE's fast track

ReNeuron Group said the US Food and Drug Administration (FDA) has granted Fast Track designation to its human Retinal Progenitor Cell (hRPC) therapy candidate for retinitis pigmentosa (RP).